𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma

✍ Scribed by Muller, D; Millon, R; Théobald, S; Hussenet, T; Wasylyk, B; du Manoir, S; Abecassis, J

Book ID
109998764
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
161 KB
Volume
94
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MicroRNA alterations in head and neck sq
MicroRNA alterations in head and neck squamous cell carcinoma
✍ Steven S. Chang; Wei Wen Jiang; Ian Smith; Luana M. Poeta; Shahnaz Begum; Chad G 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 244 KB 👁 1 views

## Abstract MicroRNAs (mirs) are small noncoding RNA molecules (∼22 nucleotides) that regulate posttranscriptional gene expression. Currently, there has not been a comprehensive study of their role in primary head and neck squamous cell carcinoma (HNSCC). To determine the role of mirs in HNSCC, we

PRAD-1 (CCND1)/Cyclin D1 oncogene amplif
PRAD-1 (CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma
✍ Troy Callender; Adel K. El-Naggar; Ming S. Lee; Robert Frankenthaler; Mario A. L 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 657 KB

## Background. Abnormalities in chromosome llq13 regions have been frequently found in head and neck squamous carcinoma. Recent studies indicate that the PRAD-1 (also CCNDI), which encodes cyclin D1, is a putative oncogene that is an important component of this region. Methods. DNA was extracted

Altered expression and activity of G1/S
Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck
✍ Vyomesh Patel; Judit Jakus; Candice M. Harris; John F. Ensley; Keith C. Robbins; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 2 views

Progressive deregulation of the cell-division cycle is thought to contribute to the establishment and progression of neoplasia. Previously, we have documented the in vivo inactivation of p16 INK4A , an inhibitor of G 1 cyclin-dependent kinases, in squamous cell carcinomas of the head and neck region